 |
|
Gender, coupled with diabetes, affects vascular disease development
August 16, 2007Austin, TX - Diabetes is associated with the development of vascular (blood vessel) disease. As we age, vascular disease becomes more common. It has been thought that females may be more susceptible to the earlier development of vascular disease, as vascular changes are observed in females long before any significant development occurs in males. Now, a team of Georgetown University researchers has determined that the vascular activities in diabetic animals vary according to sex. This discovery may eventually have implications for the way males and females are treated medically in the future.
The Study
The study, entitled "Sex Differences in Response to Vasoactive Substances in Early Uncontrolled Diabetes," was conducted by Adam Mitchell, Adam Myers and Susan Mulroney, all of the Department of Physiology and Biophysics, Georgetown University, Washington, DC. Mr. Mitchell presented the status of the team¡¦s findings at the conference, Sex and Gender in Cardiovascular-Renal Physiology and Pathophysiology. The meeting, sponsored by the American Physiological Society (APS; www.The-APS.org), was held August 9-12, 2007 in Austin, TX.
The Study
The researchers examined the notion that very early changes in artery activity exists in diabetic animals and differ by sex. To test their hypothesis they divided adult male and female rats into three groups. The first group (control) received no treatment. The second group received streptozotocin (STZ) to induce diabetes. The third group received STZ plus growth hormone (GH), which is thought to exacerbate disease progression in diabetes.
After eight weeks, the vascular reactivity to phenylephrine, which increases blood pressure, and acetylcholine, which reduces blood pressure, was measured in the vessels from the animals. Vascular response to these substances was also observed during exposure to L-NAME (which blocks production of nitric oxide, a potent artery relaxer) and neuropeptide Y (which augments the restriction of blood vessels).
The investigators found that:
* in the early stage of the disease, both male and female diabetics experienced significant decreases in the reactivity (i.e., how responsive the vessel is to a drug) of their blood vessels when exposed to acetylcholine. This occurred independent of the GH injections.
* while female diabetic rats had an increased response to phenylephrine, there was no such change among their male counterparts.
* female controls had a larger change in phenyleprine reactivity in the presence of L-NAME than did diabetic females, indicating that the diabetic females had a reduced level of nitric oxide, which dilates the artery and increases blood flow.
* diabetic males had the opposite reaction of diabetic females when exposed to phenylephrine and L-NAME. The diabetic males also produced more nitric oxide than did their controls.
* all diabetic rats exposed to growth hormone showed an increase in nitric oxide, regardless of gender.
Conclusions
The findings support the researchers¡¦ hypothesis of the existence of sex-related changes in vascular activity in diabetic animals. While the production of NO is significantly altered in the diabetic rats, the results show that gender and the presence of GH greatly contribute to this vascular dysfunction. According to Mitchell, "These findings show the importance of sex differences to understanding development of vascular problems early in diabetes and has implications on potential sex-specific therapeutic intervention."
American Physiological Society
The Study
The researchers examined the notion that very early changes in artery activity exists in diabetic animals and differ by sex. To test their hypothesis they divided adult male and female rats into three groups. The first group (control) received no treatment. The second group received streptozotocin (STZ) to induce diabetes. The third group received STZ plus growth hormone (GH), which is thought to exacerbate disease progression in diabetes.
After eight weeks, the vascular reactivity to phenylephrine, which increases blood pressure, and acetylcholine, which reduces blood pressure, was measured in the vessels from the animals. Vascular response to these substances was also observed during exposure to L-NAME (which blocks production of nitric oxide, a potent artery relaxer) and neuropeptide Y (which augments the restriction of blood vessels).
The investigators found that:
* in the early stage of the disease, both male and female diabetics experienced significant decreases in the reactivity (i.e., how responsive the vessel is to a drug) of their blood vessels when exposed to acetylcholine. This occurred independent of the GH injections.
* while female diabetic rats had an increased response to phenylephrine, there was no such change among their male counterparts.
* female controls had a larger change in phenyleprine reactivity in the presence of L-NAME than did diabetic females, indicating that the diabetic females had a reduced level of nitric oxide, which dilates the artery and increases blood flow.
* diabetic males had the opposite reaction of diabetic females when exposed to phenylephrine and L-NAME. The diabetic males also produced more nitric oxide than did their controls.
* all diabetic rats exposed to growth hormone showed an increase in nitric oxide, regardless of gender.
Conclusions
The findings support the researchers¡¦ hypothesis of the existence of sex-related changes in vascular activity in diabetic animals. While the production of NO is significantly altered in the diabetic rats, the results show that gender and the presence of GH greatly contribute to this vascular dysfunction. According to Mitchell, "These findings show the importance of sex differences to understanding development of vascular problems early in diabetes and has implications on potential sex-specific therapeutic intervention."
American Physiological Society
Vascular Disease Current Events and Vascular Disease News RSSAdding ezetimibe to atorvastatin improves lipid control
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone.
Obesity may hinder optimal control of blood pressure and cholesterol
Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD).
Radiologists find a technique to significantly reduce patient radiation dose during CT angiography
Radiologists have discovered that prospective electrocardiogram (ECG) gating allows them to significantly reduce the patient radiation dose delivered during computed tomography (CT) angiography, a common noninvasive technique used to evaluate vascular disease.
Many Australians at risk of cardiovascular disease are not receiving best practice care
Many people are not receiving the best possible care when it comes to managing cardiovascular conditions according to two new Australian research studies.
Link between depression, early stages of chronic kidney disease found by researchers
One in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease, UT Southwestern Medical Center researchers have found.
Team reveals molecular mechanism underlying a form of diabetes
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion.
Surprising rate of recurring heart attacks, strokes globally
Despite many medicines and other treatments for patients with vascular disease, a large international study shows these patients have a surprisingly high rate of recurring events such as strokes, heart attacks and hospitalizations as well as mortality.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
More Vascular Disease Current Events and Vascular Disease News Articles
 |
Handbook of Patient Care in Vascular Diseases (Lippincott Williams & Wilkins Handbook) by Todd E Rasmussen (Author), W. Darrin Clouse (Author), Britt H Tonnessen (Author) Completely revised by a team of new authors with expertise in endovascular procedures, this handbook is a quick reference for the effective treatment of patients with common arterial and venous diseases. In concise outline format, the book covers all major vascular disorders, including peripheral vascular diseases, and emphasizes patient management issues rather than step-by-step surgical procedures. This Fifth Edition covers common endovascular procedures and their preoperative and postoperative management issues. A major section provides disease-specific care outlines for various vascular disease categories, with references to the contemporary literature. From diagnosis to follow-up, each chapter includes indications for therapy, periprocedural management, and valuable tips on avoiding... |
|
South African Journal of Diabetes and Vascular Disease by Clinics Cardive Publishing Co | |
 |
FlameEz-Vascular, 60 Capsules/Bottle by FlameEz Inflammation plays a key role in plaque building up in coronary arteries, which leads to heart disease and heart attack. At the early stage, the plaque can build up quickly in inflamed arteries. If inflammatory conditions persist, the plaque can expand rapidly causing blood vessel narrowing. In advanced stage, inflammation leads to development of "soft" plaque that can rupture suddenly and cause heart attack. For many, cardiovascular disease is a silent disease, with no visible signs or symptoms until it suddenly leads to a heart attack or stroke. It is widely accepted that control of inflammation may yield a more ‘stable’ plaque that less likely to rupture. However, there are currently no medications available for direct treatment of the underlying chronic inflammation associated... |
 |
Vascular Medicine - A Companion to Braunwald's Heart Disease Expert Consult Online and Print by Mark A. Creager (Author), Victor J. Dzau (Author), Joseph Loscalzo (Author) Tap into the latest knowledge and approaches to vascular medicine with the comprehensive, clinically oriented coverage of this new addition to the Braunwald’s Heart Disease family. You’ll find today’s best methods for identifying and treating arterial diseases of the limbs * renal, mesenteric and cerebral circulation problems * aortic aneurysms * vasospastic diseases * vasculitides * venous thromboembolisms * lymphedema * and much more. * Integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular disease. * Covers the fundamental biology of blood vessels and the pathobiologic foundation of vascular disease. * Provides an in-depth, state-of-the-art review of all vascular diseases with emphasis on pathophysiology, diagnosis, and management.... |
 |
Cognitive Aging and Alzheimer's Disease: Gender Matters What is normal versus abnormal cognitive function in women, versus men, and how does dementia make itself known? What can be done to prevent Alzheimer's Disease? |
|
Diagnostic and Therapeutic Approaches to Vascular Disease [VHS] Starring: University of Washington School of Medicine | |
 |
Retinal Vascular Disease by A.M. Joussen (Editor), T.W. Gardner (Editor), B. Kirchhof (Editor), S.J. Ryan (Editor) Vascular diseases of the retina are a major cause of blindness among all age groups. Edited and written by internationally well-known experts, this state-of-the-art comprehensive overview of basic and clinical science will enhance the understanding of retinal vascular disease and help in the evaluation of current and future treatment approaches for the clinician. The well-structured and highly illustrated text is divided into the following three main sections: |
|
Vascular Disease Management by Hmp Communications | |
 |
Handbook Of Patient Care In Vascular Diseases by Lippincott Williams & Wilkins Handbook of Patient Care in Vascular Diseases : Handbook of Patient Care in Vascular Diseases Pub Date: June 2008 Product Type: Print Author/s: Todd E Rasmussen MD, FACS; W. Darrin Clouse MD, FACS; Britt H Tonnessen MD Completely revised by a team of new authors with expertise in endovascular procedures, this handbook is a quick reference for the effective treatment of patients with common arterial and venous diseases. In concise outline format, the book covers all major vascular disorders, including peripheral vascular diseases, and emphasizes patient management issues rather than step-by-step surgical procedures.This Fifth Edition covers common endovascular procedures and their preoperative and postoperative management issues. A major section provides... |
 |
Mechanisms of Vascular Disease: A Textbook for Vascular Surgeons by Robert Fitridge (Editor), Matthew Thompson (Editor) This textbook provides an up-to-date account of the mechanisms and pathophysiology of vascular disease, and the current treatment options open to vascular surgeons. As the scientific basis of vascular disease advances rapidly, it is critical that clinicians have access to relevant information written specifically for vascular surgeons. This account reviews the impact of these scientific advances on established and emerging treatment options. Experts from Australia, North America and Europe have contributed to basic topics such as atherosclerosis, restenosis, thrombosis and hemostasis, ischaemia-reperfusion injury, sepsis, vascular hemodynamics and wound healing. More applied topics such as pain syndromes in vascular surgery and the diabetic foot are also covered in this textbook. This... |
| © 2009 BrightSurf.com |